Immunothérapie des cancers par oligonucléotides immunostimulants
Med Sci (Paris), 21 1 (2005) 73-77
Published online: 2005-01-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Bivalent OX40 Aptamer and CpG as Dual Agonists for Cancer Immunotherapy
Tingting Jiang, Zailin Yang, Qiuyu Su, Liang Fang, Qing Xiang, Cheng Tian, Qinlin Gao, Chengde Mao, Cheng Zhi Huang and Hua ZuoACS Applied Materials & Interfaces 17 (5) 7353 (2025)
https://doi.org/10.1021/acsami.4c18550
Immune Modulator and Low-Temperature PTT-Induced Synergistic Immunotherapy for Cancer Treatment
Yue Duan, Han Yang, Junxiao Gao, et al.ACS Applied Bio Materials 4 (2) 1524 (2021)
https://doi.org/10.1021/acsabm.0c01397
Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application
Ling Bai, Wei Chen, Jingtao Chen, et al.Journal of Translational Medicine 15 (1) (2017)
https://doi.org/10.1186/s12967-017-1152-5
The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways
M. Duhamel, F. Rodet, A. N. Murgoci, et al.Scientific Reports 6 (1) (2016)
https://doi.org/10.1038/srep19360
Radio-immunothérapie alpha
Jérémie Ménager, Jean-Baptiste Gorin, Nolwenn Fichou, et al.médecine/sciences 32 (4) 362 (2016)
https://doi.org/10.1051/medsci/20163204014
Vectorization of Nucleic Acids for Therapeutic Approach: Tutorial Review
Frederic Geinguenaud, Erwann Guenin, Yoann Lalatonne and Laurence MotteACS Chemical Biology 11 (5) 1180 (2016)
https://doi.org/10.1021/acschembio.5b01053
Macromolecular Anticancer Therapeutics
Anne Laure Ramon and Claude MalvyMacromolecular Anticancer Therapeutics 539 (2010)
https://doi.org/10.1007/978-1-4419-0507-9_16
Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI‐124 in a mouse melanoma tumor model
Ommoleila Molavi, Zengshuan Ma, Samar Hamdy, Raymond Lai, Afsaneh Lavasanifar and John SamuelImmunology & Cell Biology 86 (6) 506 (2008)
https://doi.org/10.1038/icb.2008.27
Pretransplant treatment of donors with immunomodulators to control graft-versus-host disease (GVHD) in transplant recipients
Shoshana Morecki, Elena Yacovlev, Yael Gelfand, Osnat Eizik and Shimon SlavinExperimental Hematology 35 (5) 748 (2007)
https://doi.org/10.1016/j.exphem.2007.01.050
Immune Mechanisms and Therapeutic Potential of CpG Oligodeoxynucleotides
Heather L. Wilson, Arshud Dar, Scott K. Napper, et al.International Reviews of Immunology 25 (3-4) 183 (2006)
https://doi.org/10.1080/08830180600785868